Monday, October 13, 2008
pehel.com
Home Latest News Pakistan World Science / Technology Sports Entertainment Health Business


FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion
Source: Medical News Today E-Mail this News Story to a friend E-Mail this Story
Category: Health
Publication Date: Sat, 19 Jul 2008 01:00:00 PDT
News URL: http://www.medicalnewstoday.com/articles/115508.php
FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual DysfuntionBioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) announced today that it successfully has completed and reached an additional agreement with the U.S.
Click here for full Story
http://www.medicalnewstoday.com/articles/115508.php
Bookmark this news story online:
Add FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to BlinkListAdd FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to DeliciousAdd FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to DiggAdd FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to FarkAdd FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to FurlAdd FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to BlogarithmAdd FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to MeneameAdd FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to My Yahoo!Add FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to ReddItAdd FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to ShadowsAdd FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to SimpyAdd FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to SpurlAdd FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to Sync2ItAdd FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to MagnoliaAdd FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to NewsVineAdd FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to Ask Jeeves
Add FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to Raw SugarAdd FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to DiigoAdd FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to NetVouzAdd FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to Stumble UponAdd FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to SegnaloAdd FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to Google BookmarksAdd FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to Microsoft LiveAdd FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to BlogMarksAdd FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to WinkAdd FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to TechnoratiAdd FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to Feed Me LinksAdd FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to LinkaGoGoAdd FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to BlueDotAdd FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to Mister WongAdd FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to TailRankAdd FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel® In FSD For Female Sexual Dysfuntion to Yahoo Bookmarks

Comments

No comments found... be the first one to comment on this story :)

Post a Comment
Name:
   
E-Mail Address:
   
Website / Blog URL (optional):
   
Comments:
   
Security Code:
   
  
   By submitting these comments, you are agreeing to our Terms of Service
    
Latest News
Latest News World News Pakistan News Technology News Entertainment News Business News Sports News
bullet Washington Post Examines Mental Health Parity Law
bullet HIV Drug Resistance Spreading In China, Researcher Says
bullet New Virus From Arenaviridae Family In South Africa And Zambia - World Health Organization
bullet Medicare's Online Tools Will Help Beneficiaries With Prescription Drug And Health Plan Choices For 2009, USA
bullet Doctors Without Borders Protests Comments By Bernard Kouchner In Jerusalem
bullet International Community Failing Civilians In North Kivu, Congo - Doctors Without Borders
bullet Panel Discusses How Asian Migrant Women Are Vulnerable To HIV
bullet Intravesical Chondroitin Sulphate Shows Promise For Treatment Of Bladder Pain Syndrome
bullet Treatment Of Bladder Pain Syndrome/Interstitial Cystitis 2008: Can We Make Evidence-Based Decisions?
bullet CEO Roundtable On Cancer Offers "Common Language" To Jump Start Cancer Clinical Trials
bullet Obese Teenagers Face Higher Metabolic Syndrome Risk In South America Than Europe
bullet Almost 60% Of Europeans Never Heard Of Neuropathic Pain (NeP), Which Affects 22 Million People
bullet Convincing Results Of Solianis' Multisensor System In Home-Use Trial
bullet National Patient Choice Survey Latest Results - Department Of Health, UK
bullet Seeds Of Optimism In Iraq's Mental Health Provision
bullet Former Bond Girl Ursula Andress Urges Women To Say "Doctor: No" To Osteoporosis
bullet Medtronic's Third-Generation Endeavor® Resolute Drug-Eluting Stent Maintains Strong Efficacy And Safety Profile At Two Years
bullet Cedars-Sinai Medical Center's Stroke Program Awarded Joint Commission Certification As A Primary Stroke Center
bullet New Informa Journal Article Clarifies Understanding Of Post-Operative Visual Loss
bullet Efforts Address Health Care Inequities, Offer No-Cost Care To Hispanics, Create Media Health Awareness Projects Targeting Immigrants
bullet Who Will Voters Choose To Tackle Nation's Health Care Problems? USA
bullet Pandemic Flu Models Improve Food, Quarantine Strategies
bullet FDA Licenses For Marketing New Therapy For Rare Genetic Disease
bullet FDA Approves Rapaflo For The Treatment Of Symptoms Due To An Enlarged Prostate Gland
bullet FDA Launches Food Defense Awareness Training Kit For Employees In The Food Industry
 
© 2007 Verge Systems